Connection

Terry Day to Neoplasm Staging

Back to Details
This is a "connection" page, showing publications Terry Day has written about Neoplasm Staging.
Terry Day
Connection Strength
1.581
Neoplasm Staging
  1. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
    View in: PubMed
    Score: 0.367
  2. Melanoma of the head and neck. Curr Treat Options Oncol. 2005 Jan; 6(1):19-30.
    View in: PubMed
    Score: 0.197
  3. Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer. Head Neck. 2020 09; 42(9):2687-2695.
    View in: PubMed
    Score: 0.143
  4. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.129
  5. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
    View in: PubMed
    Score: 0.124
  6. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.121
  7. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.114
  8. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
    View in: PubMed
    Score: 0.108
  9. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug; 52(4):195-215.
    View in: PubMed
    Score: 0.041
  10. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.039
  11. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.037
  12. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.036
  13. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.035
  14. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
    View in: PubMed
    Score: 0.032
  15. Respiratory-swallow phase patterns and their relationship to swallowing impairment in patients treated for oropharyngeal cancer. Head Neck. 2010 Apr; 32(4):481-9.
    View in: PubMed
    Score: 0.018
  16. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
    View in: PubMed
    Score: 0.016
  17. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.016
  18. Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol. 1994 Jul; 54(1):35-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.